Metoclopramide Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Metoclopramide Hydrochloride Price Trend, Index and Forecast
Track the latest insights on metoclopramide hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Metoclopramide Hydrochloride Prices Outlook Q4 2025
- USA: USD 151434/MT
- China: USD 124075/MT
- Germany: USD 147354/MT
- Mexico: USD 128435/MT
- Brazil: USD 143098/MT
Metoclopramide Hydrochloride Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the fourth quarter of 2025, the metoclopramide hydrochloride prices in the USA reached 151434 USD/MT in December. Prices increased, supported by steady procurement from pharmaceutical formulators and structured institutional demand within hospital supply chains. Additionally, regulated production standards and controlled API output levels shaped domestic availability across prescription drug distribution channels.
During the fourth quarter of 2025, the metoclopramide hydrochloride prices in China reached 124075 USD/MT in December. Prices rose, driven by active export participation and consistent procurement from domestic generic drug manufacturers. Integrated raw material sourcing and disciplined plant utilization influenced supply positioning within the bulk API segment.
During the fourth quarter of 2025, the metoclopramide hydrochloride prices in Germany reached 147354 USD/MT in December. Prices moved upward, influenced by structured distributor restocking and steady hospital demand. Compliance-focused production and calibrated inventory management shaped transactional activity within the regulated pharmaceutical market.
During the fourth quarter of 2025, the metoclopramide hydrochloride prices in Mexico reached 128435 USD/MT in December. Prices increased, supported by firm procurement from domestic pharmaceutical companies and coordinated import flows. Regional redistribution networks and distributor inventory alignment influenced supply conditions.
During the fourth quarter of 2025, the metoclopramide hydrochloride prices in Brazil reached 143098 USD/MT in December. Prices edged higher, driven by steady demand from hospital procurement programs and consistent generic drug formulation activity. Import dependence and inland logistics coordination shaped material availability across key healthcare markets.
Metoclopramide Hydrochloride Prices Outlook Q3 2025
- USA: USD 144982/MT
- China: USD 121773/MT
- Germany: USD 142591/MT
- Mexico: USD 121417/MT
- Brazil: USD 137435/MT
During the third quarter of 2025, the metoclopramide hydrochloride prices in the USA reached 144982 USD/MT in September. Prices increased, supported by sustained demand from pharmaceutical formulators and structured procurement under institutional healthcare programs. Stable domestic production and compliance-driven manufacturing standards shaped availability.
During the third quarter of 2025, the metoclopramide hydrochloride prices in China reached 121773 USD/MT in September. Prices declined, influenced by moderated export demand and balanced API production output. Structured raw material sourcing and sufficient manufacturing capacity shaped supply conditions across the bulk pharmaceutical segment.
During the third quarter of 2025, the metoclopramide hydrochloride prices in Germany reached 142591 USD/MT in September. Prices moved lower, reflecting calibrated distributor inventories and measured procurement from hospital networks. Regulated pricing mechanisms and steady domestic supply influenced transactional activity.
During the third quarter of 2025, the metoclopramide hydrochloride prices in Mexico reached 121417 USD/MT in September. Prices decreased, supported by moderated import demand and cautious purchasing from pharmaceutical manufacturers. Structured logistics and balanced inventory positioning shaped regional availability.
During the third quarter of 2025, the metoclopramide hydrochloride prices in Brazil reached 137435 USD/MT in September. Prices increased, driven by firm procurement from domestic healthcare programs and steady formulation demand. Coordinated import scheduling and distributor stock management influenced supply conditions.
Metoclopramide Hydrochloride Prices Outlook Q2 2025
- USA: USD 140310/MT
- China: USD 125410/MT
- Germany: USD 145665/MT
- Mexico: USD 122780/MT
- Brazil: USD 131580/MT
During the second quarter of 2025, the metoclopramide hydrochloride prices in the USA reached 140310 USD/MT in June. In the USA, metoclopramide hydrochloride prices were influenced by steady demand from hospitals, clinics, and pharmaceutical distributors. Domestic production costs were shaped by feedstock availability, energy tariffs, and labor expenses. Imports from Asia supplemented supply, with landed costs affected by freight charges, port handling, and customs documentation. Compliance with Food and Drug Administration regulations for quality and safety added testing and certification costs. Inland logistics, including warehousing and long-haul trucking, further contributed to distribution expenses.
During the second quarter of 2025, metoclopramide hydrochloride prices in China reached 125410 USD/MT in June. In China, metoclopramide hydrochloride prices were driven by demand from domestic healthcare systems and pharmaceutical manufacturers, as well as exports to global markets. Production economics were influenced by the availability of raw materials, energy tariffs, and local labor conditions. Export volumes to North America and Europe impacted domestic allocation. Inland transport, port congestion, and shipping costs added to supply chain pressures, while compliance with pharmaceutical safety and environmental regulations increased overall production-related expenses.
During the second quarter of 2025, the metoclopramide hydrochloride prices in Germany reached 145665 USD/MT in June. In Germany, metoclopramide hydrochloride prices were shaped by consumption in the healthcare and pharmaceutical manufacturing sectors. Supply relied on both domestic production and imports, with freight charges, customs duties, and port handling shaping landed costs. High energy tariffs and labor costs influenced production economics, while strict European Union regulations required comprehensive testing and certification, adding compliance-related expenses. Inland distribution, including warehousing and trucking across multiple countries, further contributed to procurement and supply chain costs.
During the second quarter of 2025, the metoclopramide hydrochloride prices in Mexico reached 122780 USD/MT in June. In Mexico, metoclopramide hydrochloride prices were influenced by demand from hospitals, pharmacies, and pharmaceutical distributors. Supply was supported by a mix of domestic production and imports, with landed costs affected by international shipping rates, port logistics, and customs clearance. Currency fluctuations against the US dollar played a significant role in procurement expenses. Domestic logistics, including road transport and storage, added to overall supply chain costs, while regulatory compliance with national pharmaceutical safety standards increased certification expenses.
During the second quarter of 2025, the metoclopramide hydrochloride prices in Brazil reached 131580 USD/MT in June. In Brazil, metoclopramide hydrochloride prices were guided by demand from public and private healthcare providers. Limited domestic production created reliance on imports, making costs sensitive to global freight rates, port inefficiencies, and customs regulations. Currency volatility of the Brazilian real against the US dollar strongly influenced procurement dynamics. Domestic logistics challenges, including long-haul trucking and infrastructure limitations, added to supply chain costs. Compliance with national health authority regulations further increased certification and quality assurance expenses for both importers and distributors.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the metoclopramide hydrochloride prices.
Europe Metoclopramide Hydrochloride Price Trend
Q4 2025:
As per the metoclopramide hydrochloride price index, European prices moved upward, influenced by structured procurement from hospital systems and regulated pharmaceutical distributors. Centralized warehousing across Western Europe and compliance-driven manufacturing standards shaped supply positioning. Demand from institutional healthcare networks and coordinated import flows influenced transactional activity within the region’s generic drug market.
Q3 2025:
European prices moved downward overall, influenced by moderated distributor restocking and calibrated hospital procurement cycles. Balanced API production and controlled inventory management shaped availability across regulated pharmaceutical channels.
Q2 2025:
As per the metoclopramide hydrochloride price index, European prices were shaped by demand from hospitals, clinics, and pharmaceutical distributors. Supply was influenced by both domestic production and imports from Asia, with freight charges, port operations, and customs duties affecting landed costs. High energy tariffs and labor expenses increased production pressures within the region. Compliance with European Union pharmaceutical regulations, including rigorous testing, traceability, and certification, added to operational costs. Inland logistics, including cross-border trucking and warehousing, further contributed to procurement dynamics across key healthcare markets.
This analysis can be extended to include detailed metoclopramide hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Metoclopramide Hydrochloride Price Trend
Q4 2025:
As per the metoclopramide hydrochloride price index, prices in North America increased, driven by steady institutional demand and structured supply agreements within the prescription drug segment. Stable domestic API manufacturing and coordinated distribution networks supported predictable supply conditions across healthcare systems.
Q3 2025:
Prices in North America moved upward, supported by consistent pharmaceutical formulation demand and structured government procurement programs. Integrated domestic production and distributor inventory alignment shaped market dynamics.
Q2 2025:
As per the metoclopramide hydrochloride price index, in North America, metoclopramide hydrochloride prices were influenced by demand from hospitals, pharmacies, and large healthcare networks. Supply relied on domestic production supplemented by imports, with freight rates, customs documentation, and port congestion shaping landed costs. Feedstock availability and production inputs influenced manufacturing expenses, while compliance with stringent Food and Drug Administration regulations added certification and quality assurance costs. Inland distribution, including warehousing and long-haul trucking, further increased expenses, particularly given the extensive healthcare distribution system across the region.
Specific metoclopramide hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Metoclopramide Hydrochloride Price Trend
Q4 2025:
As per metoclopramide hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q3 2025:
The report explores the metoclopramide hydrochloride pricing trends and metoclopramide hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
As per the metoclopramide hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.
In addition to region-wise data, information on metoclopramide hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Metoclopramide Hydrochloride Price Trend
Q4 2025:
Across Asia Pacific, metoclopramide hydrochloride prices moved upward, supported by active export demand from major API manufacturing hubs and steady domestic pharmaceutical procurement. Disciplined plant operating rates and integrated raw material sourcing ensured consistent production continuity. Structured trade flows across regional pharmaceutical clusters influenced supply alignment.
Q3 2025:
Across Asia Pacific, metoclopramide hydrochloride prices moved downward overall, influenced by moderated export demand from major API manufacturing hubs and calibrated procurement from domestic pharmaceutical formulators. Balanced plant operating rates and structured raw material sourcing ensured steady production continuity. Distributor inventory adjustments and regulated distribution frameworks shaped supply availability across the region’s bulk API network.
Q2 2025:
In Asia Pacific, metoclopramide hydrochloride prices were driven by demand from pharmaceutical producers, hospitals, and export markets, with China and India acting as key suppliers. Production economics were shaped by the availability of fermentation feedstocks, energy tariffs, and local labor conditions. Export volumes to Europe and North America influenced domestic allocation, while inland transportation and port handling costs impacted logistics expenses. Regulatory compliance with international standards, such as Good Manufacturing Practices, added further costs, particularly for exporters serving highly regulated markets abroad.
This metoclopramide hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Metoclopramide Hydrochloride Price Trend
Q4 2025:
Latin America indicated an upward pricing direction for metoclopramide hydrochloride, supported by firm hospital procurement programs and structured import positioning. Distributor-level stock calibration and coordinated inland logistics influenced supply conditions within public healthcare networks.
Q3 2025:
Regional market assessments across Latin America reflected a mixed pricing environment for metoclopramide hydrochloride, shaped by firmer pharmaceutical procurement in some markets alongside moderated purchasing in others. Structured import positioning and distributor-level inventory calibration influenced transactional activity, while hospital and institutional demand remained aligned with scheduled healthcare procurement programs.
Q2 2025:
In Latin America, especially Brazil, metoclopramide hydrochloride prices were shaped by demand from public and private healthcare providers. Limited domestic production increased reliance on imports, making procurement highly sensitive to international shipping charges, port inefficiencies, and customs clearance. Currency volatility of the Brazilian real against the US dollar significantly influenced landed expenses. Domestic logistics challenges, including long-haul trucking and infrastructure limitations, added to distribution costs. Compliance with national pharmaceutical regulations further increased testing and certification requirements, shaping procurement strategies across the regional market.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Metoclopramide Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Metoclopramide Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the metoclopramide hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of metoclopramide hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed metoclopramide hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting metoclopramide hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Metoclopramide Hydrochloride Industry Analysis
The global metoclopramide hydrochloride industry size reached USD 4.9 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 6.5 Billion, at a projected CAGR of 3.10% during 2026-2034. Market growth is driven by sustained demand for antiemetic and gastrointestinal therapies, expanding healthcare access in emerging economies, increasing generic drug production, and continued institutional procurement across public and private healthcare systems.
Latest News and Developments:
- August 2025: [SS1] The South African Health Products Regulatory Authority (SAHPRA) published the finalized Professional Information (PI) document for metoclopramide hydrochloride 10 mg tablets, confirming updated prescribing guidance, safety information, dosage recommendations, and contraindications. The document outlines reinforced warnings regarding extrapyramidal side effects, tardive dyskinesia risk with prolonged use, and recommended duration limits for metoclopramide hydrochloride therapy.
Product Description
Metoclopramide hydrochloride is an antiemetic often used in cases of nausea and vomiting, delayed stomach emptying, or gastroparesis. It also assists in the treatment of gastroesophageal reflux disease widely referred to as GERD as well as postoperative nausea and vomiting when used as a complementary treatment with chemotherapy or surgery. They are effective through their receptors’ antagonism of dopamine within the chemoreceptor trigger zone of the gastrointestinal tract and additionally, it influences the serotonin receptors.
The production process of metoclopramide hydrochloride entails chemical synthesis in which organic reactions leading to the formation of API are carried out. This process is carried out under regulation to make sure that the drug is pure and will achieve the intended goal that it was manufactured for. The role of metoclopramide hydrochloride stems from the relief of such profound symptoms of nausea and retarded gastric motility, which is a genuine detriment to a patient’s lifestyle. It applies to almost all clinical conditions and is considered a significant component of therapeutic interfaces for patients with different GI and chemotherapy problems.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Metoclopramide Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Metoclopramide Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of metoclopramide hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting metoclopramide hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The metoclopramide hydrochloride price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.